Omnipaque sets a standard for LOCM as a class

Worldwide, LOCM are now used in 75% of patients receiving contrast media[2]

Several large studies across the globe have shown that LOCM, including Omnipaque, are associated with fewer adverse events than HOCM[1,4-7]

image

(Click to magnify)